Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to Devgen, Sanofi, Venganza, and More


Title: Method of Treating Malignant Mesothelioma

Patent Number: 8,771,688

Filed: Feb. 7, 2012

Lead Inventor: Chikao Morimoto, University of Tokyo

Title: Method and Constructs for Delivering Double-stranded RNA to Pest Organisms

Patent Number: 8,772,254

Filed: Oct. 25, 2005

Lead Inventor: Thierry Bogaert, Devgen (Syngenta)

Title: Cell-transfecting Formulations of Small Interfering RNA-related Compositions and Methods of Making and Use

Patent Number: 8,772,255

Filed: March 21, 2008

Lead Inventor: Timothy Burkoth, Novartis Vaccines and Diagnostics

Title: Single-walled Carbon Nanotube/siRNA Complexes and Methods Related Thereto

Patent Number: 8,772,258

Filed: July 1, 2011

Lead Inventor: D. Lynn Kirkpatrick, Ensysce Biosciences

Title: Preventive or Therapeutic Agent for Fibrosis

Patent Number: 8,772,262

Filed: Oct. 14, 2011

Lead Inventor: Esteban Gabazza, Otsuka Pharmaceutical

Title: Synthetic Double-stranded Oligonucleotides for Specific Inhibiting on Gene Expression

Patent Number: 8,772,469

Filed: July 11, 2002

Lead Inventor: Eugen Uhlmann, Sanofi

Title: Compositions and Methods for Treatment of Prostate and Other Cancers

Patent Number: 8,772,470

Filed: Nov. 30, 2007

Lead Inventor: Martin Gleave, University of British Columbia

Title: Targeted Delivery of siRNA

Patent Number: 8,772,471

Filed: Jan. 25, 2008

Lead Inventor: Premlata Shankar, Immune Disease Institute (Harvard Medical School)

Title: siRNA Conjugate and Preparation Method Thereof

Patent Number: 8,772,472

Filed: Sept. 13, 2012

Lead Inventor: Bo Ram Han, Bioneer

Title: Methods and Materials for Conferring Resistance to Pests and Pathogens of Plants

Patent Number: 8,772,572

Filed: April 22, 2013

Inventor: Charles Niblett, Venganza